» Articles » PMID: 35315774

Chinese Natural Compound Decreases Pacemaking of Rabbit Cardiac Sinoatrial Cells by Targeting Second Messenger Regulation of F-channels

Overview
Journal Elife
Specialty Biology
Date 2022 Mar 22
PMID 35315774
Authors
Affiliations
Soon will be listed here.
Abstract

Tongmai Yangxin (TMYX) is a complex compound of the Traditional Chinese Medicine (TCM) used to treat several cardiac rhythm disorders; however, no information regarding its mechanism of action is available. In this study we provide a detailed characterization of the effects of TMYX on the electrical activity of pacemaker cells and unravel its mechanism of action. Single-cell electrophysiology revealed that TMYX elicits a reversible and dose-dependent (2/6 mg/ml) slowing of spontaneous action potentials rate (-20.8/-50.2%) by a selective reduction of the diastolic phase (-50.1/-76.0%). This action is mediated by a negative shift of the I activation curve (-6.7/-11.9 mV) and is caused by a reduction of the cyclic adenosine monophosphate (cAMP)-induced stimulation of pacemaker channels. We provide evidence that TMYX acts by directly antagonizing the cAMP-induced allosteric modulation of the pacemaker channels. Noticeably, this mechanism functionally resembles the pharmacological actions of muscarinic stimulation or β-blockers, but it does not require generalized changes in cytoplasmic cAMP levels thus ensuring a selective action on rate. In agreement with a competitive inhibition mechanism, TMYX exerts its maximal antagonistic action at submaximal cAMP concentrations and then progressively becomes less effective thus ensuring a full contribution of I to pacemaker rate during high metabolic demand and sympathetic stimulation.

Citing Articles

Pacemaker Channels and the Chronotropic Response in Health and Disease.

Hennis K, Piantoni C, Biel M, Fenske S, Wahl-Schott C Circ Res. 2024; 134(10):1348-1378.

PMID: 38723033 PMC: 11081487. DOI: 10.1161/CIRCRESAHA.123.323250.

References
1.
Proenza C . Exploiting natural regulation. Elife. 2018; 7. PMC: 6078491. DOI: 10.7554/eLife.39664. View

2.
Fan Y, Liu J, Miao J, Zhang X, Yan Y, Bai L . Anti-inflammatory activity of the Tongmai Yangxin pill in the treatment of coronary heart disease is associated with estrogen receptor and NF-κB signaling pathway. J Ethnopharmacol. 2021; 276:114106. DOI: 10.1016/j.jep.2021.114106. View

3.
DiFrancesco D . Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol. 1993; 55:455-72. DOI: 10.1146/annurev.ph.55.030193.002323. View

4.
Sirenko S, Zahanich I, Li Y, Lukyanenko Y, Lyashkov A, Ziman B . Phosphoprotein Phosphatase 1 but Not 2A Activity Modulates Coupled-Clock Mechanisms to Impact on Intrinsic Automaticity of Sinoatrial Nodal Pacemaker Cells. Cells. 2021; 10(11). PMC: 8623309. DOI: 10.3390/cells10113106. View

5.
Milanesi R, Baruscotti M, Gnecchi-Ruscone T, DiFrancesco D . Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl J Med. 2006; 354(2):151-7. DOI: 10.1056/NEJMoa052475. View